EFFICACY OF ULIPRISTAL ACETATE FOR THE TREATMENTOF SYMPTOMATIC UTERINE LEIOMYOMAS IN AFRICAN AMERICANS

被引：2
|
作者：
Green, L. J. [1 ]
Levy, G. [2 ]
Wesley, R. [2 ]
Nieman, L. [2 ]
Armstrong, A. [2 ]
机构：
[1] Howard Univ Hosp, Obstet & Gynecol, Washington, DC USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA
来源：
FERTILITY AND STERILITY | 2012年 / 98卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2012.07.351
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-323
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [31] Unusual morphological changes of uterine leiomyomas treated with ulipristal acetate: Delineation of new characteristic histological features
    De Leo, A.
    Locatelli, F.
    Perrone, M.
    De Iaco, P.
    Corti, B.
    Santini, D.
    VIRCHOWS ARCHIV, 2017, 471 : S78 - S78
  • [32] Effect of Ulipristal Acetate for Uterine Fibroids
    Deshpande, Preeti Suhas
    Deshpande, Suhas Suresh
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (49): : 3675 - 3678
  • [33] Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids
    Donnez, Jacques
    Tomaszewski, Janusz
    Vazquez, Francisco
    Bouchard, Philippe
    Lemieszczuk, Boguslav
    Baro, Francesco
    Nouri, Kazem
    Selvaggi, Luigi
    Sodowski, Krzysztof
    Bestel, Elke
    Terrill, Paul
    Osterloh, Ian
    Loumaye, Ernest
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05): : 421 - 432
  • [34] ENDOMETRIAL SAFETY OF ULIPRISTAL ACETATE TREATMENT FOR SYMPTOMATIC UTERINE FIBROIDS IN PREMENOPAUSAL WOMEN - A SYSTEMATIC REVIEW
    Ples, Liana
    Carp, Delia
    Sima, Romina Marina
    Mirica, Alexandra
    Stanescu, Anca-Daniela
    Balalau, Denisa-Oana
    Balalau, Cristian
    FARMACIA, 2018, 66 (05) : 763 - 769
  • [35] Assessment of Endometrial Safety During Treatment of Symptomatic Uterine Fibroids With Ulipristal Acetate: VENUS II
    Eisenhut, Carol
    Smith, Donald
    Mallick, Madhuja
    Chan, Anna
    Sniukiene, Vilma
    Goldstein, Steven
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S74 - S74
  • [36] Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian costutility analysis of pharmacotherapy management
    Tsoi, Bernice
    Blackhouse, Gord
    Ferrazzi, Simon
    Reade, Clare J.
    Chen, Innie
    Goeree, Ron
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 213 - 225
  • [37] CASE SERIES OF UTERINE SARCOMAS ASSOCIATED WITH PREOPERATIVE TREATMENT WITH ULIPRISTAL ACETATE FOR SUPPOSED SYMPTOMATIC MYOMAS
    Dovnik, A.
    Pakiz, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A315 - A316
  • [38] Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial
    Osuga, Yutaka
    Nakano, Yasuaki
    Yamauchi, Yuji
    Takanashi, Masaya
    FERTILITY AND STERILITY, 2021, 116 (01) : 189 - 197
  • [39] Health-related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial EDITORIAL COMMENT
    Learman, Lee A.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (08) : 471 - 472
  • [40] Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma
    Kadhel, P.
    Smail, M.
    De Mozota, D. Borja
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (07) : 609 - 611
12345